Nearly one-third of patients diagnosed with cancer have a rare tumor. The primary goal of CCR’s research on rare tumors — from clinical studies of how rare tumors develop and progress to deep investigations of the biological factors that drive them — will always focus on discovering better treatments to improve patient outcomes. A major promise of research into rare tumors is that they may expose cancer mechanisms that also exist but can be difficult to uncover in subsets of more common tumor types. We invite you to meet some of our principal investigators conducting research in this area.
